FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070730 [Registered on: 16/07/2024] Trial Registered Prospectively
Last Modified On: 04/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Langali kalka lepa and malahara lepa in the Arshas ( piles) 
Scientific Title of Study   A Control Clinical Study to evaluate the efficacy of langali Kalka lepa and langali malahara lepa in the management of Arshas(2nd degree haemorrhoids) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrAmar Gajkosh R 
Designation  Post graduation ( shalya tantra) 
Affiliation  Alvas Ayurveda medical College and hospital vidyagiri moodubidrre. 
Address  Alvas Ayurveda medical College and hospital, Shalya tantra department,vidyagiri. moodubidrre pin code 574227

Dakshina Kannada
KARNATAKA
574227
India 
Phone  8660180899  
Fax    
Email  amar1998gajakosh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Manjunatha Bhat  
Designation  Head of department and professor of department of shalya tantra 
Affiliation  Alvas Ayurveda medical College and hospital vidyagiri moodubidrre. 
Address  Alvas Ayurveda medical College and hospital, Department of shalya tantra, vidyagiri moodubidrre pin code 574227

Dakshina Kannada
KARNATAKA
574227
India 
Phone  8660180899  
Fax    
Email  dmbg2004@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr manjunatha bhat  
Designation  Head of department, professor  
Affiliation  Alvas Ayurveda medical College and hospital vidyagiri moodubidrre. 
Address  Alvas Ayurveda medical College and hospital vidyagiri moodubidrre pin code 574227 Department - shalya tantra Room no - 05 Division - ground floor Division - ground floor

Dakshina Kannada
KARNATAKA
574227
India 
Phone  9686751182  
Fax    
Email  dmbg2004@gmail.com  
 
Source of Monetary or Material Support  
Alvas Ayurveda medical College and hospital vidyagiri moodubidrre India pin code 574227 
 
Primary Sponsor  
Name  Dr Amar Gajkosh R  
Address  Alvas Ayurveda medical College and hospital vidyagiri moodubidrre pin code 574227 
Type of Sponsor  Other [For the post graduation research ( self)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amar Gajkosh R   Alvas Ayurvedic hospital moodubidrre   Opd pf Shalya tantra department Division - ground floor Room no - 05
Dakshina Kannada
KARNATAKA 
8660180899

amar1998gajakosh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Alvas Ayurveda medical College   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K928||Other specified diseases of the digestive system. Ayurveda Condition: ARSAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Langali , Reference: Bhava prakash nighantu-guduchyadi varga , Route: Rectal, Dosage Form: Kalka/ Paste , Dose: 2(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Hareethaki choorna , Reference: Bhava prakash nighantu- haritakyadi varga, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -luke warm water ), Additional Information: -control group will be having hareethaki choorna for 14 days
3Comparator ArmProcedure-lepa, लेप (Procedure Reference: Sushruta samhita- sutra sthana 18 th chapter , Procedure details: 1.patient is advised to lie down in lithotomy position 2.Anus and surrounding parts will be cleaned with povidone iodine solution. 3.Under aseptic measures a proctoscope will be introduced into the anal canal after lubricanting it with 2%lignocaine gel and then the obturator will be removed,after noting number, position and condition of pile mass the proctoscope will be removed 4.Then a lubricanted slit proctoscope will be introduced into the anal canal and then the obturator will be removed.Haemorrhoid mass will be protruded through the slit of the proctoscope 5.Langali kalka lepa will be applied on Arshas in group B, which will be retained for 15 minutes and then it will be washed with sterile water. 6.langali Malahara Lepa will be applied on Arshas in Group c, which will be retained for 15 minutes and then it will be washed with sterile water. Paschat karma 1.patient is asked to lie down in comfortable posture for 15-20 minutes. 2.5 gm of Hareethaki choorna with Luke warm water orally is given at bed time In all the three groups )
(1) Medicine Name: Langali , Reference: Bhava prakash nighantu-guduchyadi varga , Route: Rectal, Dosage Form: Kalka/ Paste, Dose: 2(g), Frequency: od, Duration: 7 Days
4Intervention ArmDrugClassical(1) Medicine Name: Langali , Reference: Bhava prakash nighantu-guduchyadi varga , Route: Rectal, Dosage Form: Malahara/ Ointment/ Balm, Dose: 2(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient with clinical features of 2 nd degree Haemorrhoids  
 
ExclusionCriteria 
Details  Exclusion criteria
Haemorrhoids that are Thrombosed, Strangulated and Inflamed.
Haemorrhoids with Fissure in ano, Fistula in ano, Rectal polyps, CA rectum, Rectal prolapse, Inflammatory bowel disese, Proctitis, Perianal & Rectal abscess.
Patients having TB, DM, Hypertension, Coagulopathies, HIV, HBsAg positive.
Pregnant women 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Arshas ( haemorrhoids) size and degree will change And no bleeding and pain and constipation   0 th day,7 th day ,8 th day ,15th day,30 th day,45 th day 
 
Secondary Outcome  
Outcome  TimePoints 
Constipation , pain , mass per anum, bleeding   30 th Days & 45 th day  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Clinical trial, Randomised controlled,3 group, where langali single drug is used with two different formulation kalka and malahara for lepa over the Arshas which is most common disease in ano rectal disease for 7 days in each group and for control group hareethaki choorna 5grm at bed time is given . Out come is measured by grading the pain, mass degree and constipation. 
Close